PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro

INTRODUCTION: Alterations in cell cycle regulators have been implicated in human malignancies including breast cancer. PD 0332991 is an orally active, highly selective inhibitor of the cyclin D kinases (CDK)4 and CDK6 with ability to block retinoblastoma (Rb) phosphorylation in the low nanomolar ran...

Descripción completa

Detalles Bibliográficos
Autores principales: Finn, Richard S, Dering, Judy, Conklin, Dylan, Kalous, Ondrej, Cohen, David J, Desai, Amrita J, Ginther, Charles, Atefi, Mohammad, Chen, Isan, Fowst, Camilla, Los, Gerret, Slamon, Dennis J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2790859/
https://www.ncbi.nlm.nih.gov/pubmed/19874578
http://dx.doi.org/10.1186/bcr2419

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2790859/
https://www.ncbi.nlm.nih.gov/pubmed/19874578
http://dx.doi.org/10.1186/bcr2419

Ejemplares similares